Wednesday, May 04, 2022 Dr. Aly-Khan A. Lalani, B.Sc (Hons), MD, FRCPC, has been awarded the 2022 CCTG Dr. Elizabeth Eisenhauer Early Drug Development Young Investigator Award recognizing his work as a new investigator who has contributed significantly to the conduct of an IND trials. Dr. Lalani is an Assistant Professor at McMaster University and a Medical Oncologist at the Juravinski Cancer Centre. After residency training, he was awarded the TD Insurance Meloche Monnex & Alberta Medical Association Scholarship. He pursued a Fellowship in Genitourinary Oncology at Dana-Farber Cancer Institute in Boston, mentored by Dr. Toni Choueiri. He has also completed the Program in Clinical Effectiveness at the Harvard T.H. Chan School of Public Health. He is a member of the Escarpment Cancer Research Institute, and an Associate Member of the Centre for Discovery in Cancer Research (CDCR) at McMaster University. His academic interests include clinical trial design and translational work for genitourinary malignancies. He completed the CCTG New Investigator Cancer Trials Practicum, and serves on CCTG as member of the GU trial development group and IND liaison. He is the lead PI for the CYTOSHRINK clinical trial. "I am truly humbled to receive this Young Investigator Award. Dr. Eisenhauer is an international icon in the field and has set a high standard of significant and meaningful cancer research. This recognition will continue to motivate me to contribute to the conduct of clinical trials that impact how we care for our patients. My sincere thanks to CCTG, as well as my mentors, collaborators, and family for their support throughout my career."
